8-KItem 2.02 · Results of OperationsItem 9.01 · Financial Statements
DANAHER CORP /DE/ (DHR)

Danaher filed an 8‑K (Jan 12, 2026): CEO to comment on financial performance.

Filed with the SEC on · Summarized by InvestorsBot

Danaher filed an 8‑K (Jan 12, 2026): CEO to comment on financial performance. Press release (Exhibit 99.1) + presentation slides for J.P. Morgan Healthcare Conference on Jan 13, 2026 (Exhibit 99.1PRE) attached. $DHR 📢 #Danaher #JPMHealthcare

Exhibits also include an interactive XBRL cover file (Exhibit 104). 8‑K signed Jan 12, 2026 by CFO Matthew R. McGrew. Investors should review the PR and slides ahead of the Jan 13 presentation. $DHR 📊 #Earnings #Healthcare

Watch Jan 13 J.P. Morgan Healthcare remarks — CEO commentary could provide forward guidance or performance updates that move the stock. Monitor the release and conference for catalysts. $DHR ⚠️ #Danaher #Investing

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from DANAHER CORP /DE/

Danaher ($DHR) filed a Form 8‑K (Item 9.01) on Feb 17, 2026 — furnished Exhibit 99.1 (press release dated…

8-K · February 17, 2026

Danaher ($DHR) to buy Masimo ($MASI) for $180.00/share in cash under a Merger Agreement dated Feb 16,…

8-K · February 17, 2026

Danaher ($DHR) filed an 8‑K (Item 9.01) on 2/10/2026 furnishing Exhibit 104 — Cover Page Interactive Data…

8-K · February 10, 2026

Danaher director Jessica L.

8-K · February 10, 2026

Danaher filed an 8‑K (dated 1/28/2026) attaching a press release “Danaher Reports Fourth Quarter and Full…

8-K · January 28, 2026

Danaher ($DHR) furnished an 8‑K (Item 2.02) on Jan 28, 2026 announcing FY2025 financial results for the…

8-K · January 28, 2026